KR20070110847A - Ｈｉｖ 프로테아제 억제제 - Google Patents
Ｈｉｖ 프로테아제 억제제 Download PDFInfo
- Publication number
- KR20070110847A KR20070110847A KR1020077018471A KR20077018471A KR20070110847A KR 20070110847 A KR20070110847 A KR 20070110847A KR 1020077018471 A KR1020077018471 A KR 1020077018471A KR 20077018471 A KR20077018471 A KR 20077018471A KR 20070110847 A KR20070110847 A KR 20070110847A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- alk
- optionally substituted
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 C*C(N[C@](*)C(C)(C)C)=O Chemical compound C*C(N[C@](*)C(C)(C)C)=O 0.000 description 6
- IQPCACJONKIPLG-IBHRRMRLSA-N CC(C)(C)[C@@H](C(NN(CCC[C@@](Cc1ccccc1)(C(N[C@H]1c2ccccc2C[C@H]1O)=O)O)Cc(cc1)ccc1-c1cccnc1)=O)NC(OC)=O Chemical compound CC(C)(C)[C@@H](C(NN(CCC[C@@](Cc1ccccc1)(C(N[C@H]1c2ccccc2C[C@H]1O)=O)O)Cc(cc1)ccc1-c1cccnc1)=O)NC(OC)=O IQPCACJONKIPLG-IBHRRMRLSA-N 0.000 description 1
- PHUSEUPBOMQSMZ-GOSISDBHSA-N CC(C)(C)[C@@H](C(NNCc1ccccc1)=O)NC(OCc1ccccc1)=O Chemical compound CC(C)(C)[C@@H](C(NNCc1ccccc1)=O)NC(OCc1ccccc1)=O PHUSEUPBOMQSMZ-GOSISDBHSA-N 0.000 description 1
- ZFTGMALWABLQBV-UHFFFAOYSA-N CC(C)(OC1(CCC(OC)=O)Cc2ccccc2)OC1=O Chemical compound CC(C)(OC1(CCC(OC)=O)Cc2ccccc2)OC1=O ZFTGMALWABLQBV-UHFFFAOYSA-N 0.000 description 1
- GYUSVVGXDYZMCO-TYPHKJRUSA-N CC1(C)O[C@H](Cc2ccccc22)[C@H]2N1C([C@@H](CCO)Cc1ccccc1)=O Chemical compound CC1(C)O[C@H](Cc2ccccc22)[C@H]2N1C([C@@H](CCO)Cc1ccccc1)=O GYUSVVGXDYZMCO-TYPHKJRUSA-N 0.000 description 1
- NPFWJUOLRGYHLZ-RHPYNKPASA-N C[C@@H]([C@](CN(Cc(cc1)ccc1-c1cccnc1)NC([C@H](C(C)(C)C)NC(OC)=O)=O)(C(N[C@H]([C@@H](C1)O)c2c1cccc2)=O)O)c1ccccc1 Chemical compound C[C@@H]([C@](CN(Cc(cc1)ccc1-c1cccnc1)NC([C@H](C(C)(C)C)NC(OC)=O)=O)(C(N[C@H]([C@@H](C1)O)c2c1cccc2)=O)O)c1ccccc1 NPFWJUOLRGYHLZ-RHPYNKPASA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0500307 | 2005-02-10 | ||
| SE0500307-4 | 2005-02-10 | ||
| SE0502352-8 | 2005-10-25 | ||
| SE0502352 | 2005-10-25 | ||
| SE0502468-2 | 2005-11-08 | ||
| SE0502468 | 2005-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20070110847A true KR20070110847A (ko) | 2007-11-20 |
Family
ID=36128513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020077018471A Ceased KR20070110847A (ko) | 2005-02-10 | 2006-02-09 | Ｈｉｖ 프로테아제 억제제 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7807677B2 (enExample) |
| EP (1) | EP1851193B1 (enExample) |
| JP (1) | JP2008530045A (enExample) |
| KR (1) | KR20070110847A (enExample) |
| AP (1) | AP2007004079A0 (enExample) |
| AT (1) | ATE429417T1 (enExample) |
| AU (1) | AU2006212422B2 (enExample) |
| BR (1) | BRPI0607230A2 (enExample) |
| CA (1) | CA2594395A1 (enExample) |
| DE (1) | DE602006006418D1 (enExample) |
| EA (1) | EA013520B1 (enExample) |
| ES (1) | ES2326041T3 (enExample) |
| IL (1) | IL183850A (enExample) |
| MX (1) | MX2007009655A (enExample) |
| PL (1) | PL1851193T3 (enExample) |
| WO (1) | WO2006084688A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006212422B2 (en) | 2005-02-10 | 2011-08-18 | Medivir Ab | HIV protease inhibitors |
| WO2007048557A1 (en) * | 2005-10-25 | 2007-05-03 | Medivir Ab | Protease inhibitors |
| WO2008078200A2 (en) * | 2006-09-21 | 2008-07-03 | Ambrilia Biopharma Inc. | Protease inhibitors |
| US9296776B2 (en) * | 2007-07-09 | 2016-03-29 | Eastern Virginia Medical School | Substituted nucleoside derivatives with antiviral and antimicrobial properties |
| JO3090B1 (ar) * | 2009-12-11 | 2017-03-15 | Janssen Sciences Ireland Uc | 5- امينو-4- هيدروكسي-بنتويل اميدات |
| TWI513694B (zh) * | 2010-05-11 | 2015-12-21 | Amgen Inc | 抑制間變性淋巴瘤激酶的嘧啶化合物 |
| CA2817368C (en) * | 2010-12-15 | 2019-12-31 | Theravance, Inc. | Neprilysin inhibitors |
| CN103261168B (zh) * | 2010-12-15 | 2015-08-05 | 施万生物制药研发Ip有限责任公司 | 脑啡肽酶抑制剂 |
| JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2052907A1 (en) * | 1990-10-11 | 1992-04-12 | Joseph P. Vacca | Hiv protease inhibitors having symmetrical structure |
| WO1992015319A1 (en) * | 1991-03-08 | 1992-09-17 | Smithkline Beecham Corporation | Hiv protease inhibitors |
| TW409125B (en) | 1996-04-22 | 2000-10-21 | Novartis Ag | Antivirally active heterocyclic azahexane derivatives |
| SE9701245D0 (sv) * | 1997-04-04 | 1997-04-04 | Bjoern Classon | Antivirals |
| AU2006212422B2 (en) | 2005-02-10 | 2011-08-18 | Medivir Ab | HIV protease inhibitors |
-
2006
- 2006-02-09 AU AU2006212422A patent/AU2006212422B2/en not_active Ceased
- 2006-02-09 ES ES06723010T patent/ES2326041T3/es active Active
- 2006-02-09 JP JP2007554500A patent/JP2008530045A/ja not_active Withdrawn
- 2006-02-09 KR KR1020077018471A patent/KR20070110847A/ko not_active Ceased
- 2006-02-09 PL PL06723010T patent/PL1851193T3/pl unknown
- 2006-02-09 WO PCT/EP2006/001135 patent/WO2006084688A1/en not_active Ceased
- 2006-02-09 US US11/884,224 patent/US7807677B2/en not_active Expired - Fee Related
- 2006-02-09 EA EA200701692A patent/EA013520B1/ru not_active IP Right Cessation
- 2006-02-09 EP EP06723010A patent/EP1851193B1/en active Active
- 2006-02-09 CA CA002594395A patent/CA2594395A1/en not_active Abandoned
- 2006-02-09 MX MX2007009655A patent/MX2007009655A/es active IP Right Grant
- 2006-02-09 DE DE602006006418T patent/DE602006006418D1/de active Active
- 2006-02-09 BR BRPI0607230-5A patent/BRPI0607230A2/pt not_active IP Right Cessation
- 2006-02-09 AT AT06723010T patent/ATE429417T1/de not_active IP Right Cessation
- 2006-02-09 AP AP2007004079A patent/AP2007004079A0/xx unknown
-
2007
- 2007-06-11 IL IL183850A patent/IL183850A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1851193B1 (en) | 2009-04-22 |
| IL183850A (en) | 2012-01-31 |
| BRPI0607230A2 (pt) | 2009-08-25 |
| CA2594395A1 (en) | 2006-08-17 |
| AP2007004079A0 (en) | 2007-08-31 |
| EP1851193A1 (en) | 2007-11-07 |
| EA013520B1 (ru) | 2010-06-30 |
| EA200701692A1 (ru) | 2007-12-28 |
| JP2008530045A (ja) | 2008-08-07 |
| MX2007009655A (es) | 2007-09-26 |
| ES2326041T3 (es) | 2009-09-29 |
| WO2006084688A8 (en) | 2007-08-16 |
| PL1851193T3 (pl) | 2009-09-30 |
| US7807677B2 (en) | 2010-10-05 |
| IL183850A0 (en) | 2007-10-31 |
| AU2006212422A1 (en) | 2006-08-17 |
| DE602006006418D1 (de) | 2009-06-04 |
| WO2006084688A1 (en) | 2006-08-17 |
| ATE429417T1 (de) | 2009-05-15 |
| AU2006212422B2 (en) | 2011-08-18 |
| US20080249102A1 (en) | 2008-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6409001B2 (ja) | Ｈｂｖ感染に対する新規抗ウイルス剤 | |
| IL183850A (en) | Hiv protease inhibitors | |
| CN104144913B (zh) | B型肝炎抗病毒剂 | |
| AP1388A (en) | Nicotinamide derivatives | |
| KR100262056B1 (ko) | 에이치 아이 브이 (hiv)-아스파르틸 단백질 분해효소의 억제제인 설폰아미드 | |
| KR100927915B1 (ko) | 통증 치료에 유용한 ｎ-(ｎ-설폰일아미노메틸)사이클로프로판카복사마이드 유도체 | |
| US9079834B2 (en) | HIV protease inhibitors | |
| TW201617316A (zh) | 人類免疫不全症病毒複製之抑制物 | |
| UA71547C2 (uk) | Похідні 4-фенілпіридину, спосіб одержання деяких з них, фармацевтична композиція та спосіб лікування захворювань, індукованих нейрокініном 1 | |
| JP2003514910A (ja) | Ｈｉｖプロテアーゼ阻害剤としてのガンマ−ヒドロキシ−２−（フルオロアルキルアミノカルボニル）−１−ピペラジンペンタンアミド類 | |
| SK284785B6 (sk) | Farmaceutická kompozícia obsahujúca inhibítor aspartylproteázy, ktorým je sulfónamid s tetrahydrofuránovým kruhom a jeho použitie | |
| CN103249721A (zh) | 作为ttx-s阻滞剂的芳胺衍生物 | |
| JPH11511177A (ja) | 抗ウイルス性複素環式アザヘキサン誘導体 | |
| US20160257645A1 (en) | Inhibitors of human immunodeficiency virus replication | |
| US9840478B2 (en) | Piperazine derivatives as HIV protease inhibitors | |
| US10138255B2 (en) | Piperazine derivatives as HIV protease inhibitors | |
| CN101115713A (zh) | 人类免疫缺陷性病毒蛋白酶抑制剂 | |
| HK1117499A (en) | Hiv protease inhibitors | |
| WO2007048557A1 (en) | Protease inhibitors | |
| TW200804246A (en) | HIV protease inhibitors | |
| US8592429B2 (en) | 5-amino-4-hydroxypentoyl amides | |
| WO2005120503A2 (en) | N-aryl piperidine compounds for inhibiting hiv infection | |
| CA2375954A1 (en) | Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof | |
| HK1230593A1 (en) | Arylamide derivatives as ttx-s blockers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20070810 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20110209 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20130116 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20130516 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20130116 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |